CLINICAL_TRIALS
trial_result
· 2012-10-18
Clinical Trial Update: Belatacept in Liver Transplant Recipients [Phase 2]
Summary
A Phase 2 trial of belatacept for immunosuppression in liver transplant recipients was terminated; results were posted in 2012.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Bristol-Myers Squibb | Conditions: Immunosuppression in Solid Organ Transplant | Phase 2 | Status: TERMINATED | Results posted: 2012-10-18